NexGenEsis HealthcareFranchise Cost, Revenue & Review 2026
Data from FDD filing
FranchiseVerdict summary · 2026
A NexGenEsis Healthcare franchise requires a total initial investment of $168K – $363K, including a $55K franchise fee. Per the 2025 FDD, average unit revenue was $2.5M[2]. Verdict grade: A. Run a live ROI scan →
Data last verified June 18, 2026 · figures per the 2025 FDD issuance
Overview
- Investment
- $168K – $363K
- 37th pct Healthcare
- Avg gross sales
- $2.5M
- 43rd pct Healthcare
- Royalty
- N/A
- Units
- 14
- 34th pct Healthcare
- SBA default
- N/A
Quick verdict · Healthcare · color = vs category peers
Green = >15% above Healthcare avg · No shading = within ±15% · Red = >15% below avg · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Each dollar invested generates 9.5x in gross revenue, well above the typical 1.5-2.5x range.
The franchisor's auditor raised doubt about continued operations. This is a serious risk signal.
Bottom line
- Total investment $168K – $363K including a $55K franchise fee.
- Average unit revenue of $2.5M/year. Estimated payback in 0.5 years (based on EBITDA).
- Verdict A (Top Quintile) with a risk score of 44/100.
- Auditor disclosed a going-concern note, which flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
- Legal entity
- NexGen Franchising, LLC
- Parent company
- EAD NexGenix LLC
- Incorporated in
- MS
- HQ
- 5420 Dashwood St. Suite 206, Houston, Texas 77081
- Auditor
- Kezos & Dunlavy
- Audited financials
- Franchisor revenue
- $5K
- vs $204K prior year
- ⚠ Going-concern note
- Disclosed in FDD 2025
- Auditor flagged doubt about continued operations. Verify against the latest FDD before deciding.
Overview
About
NexGenEsis Healthcare franchisees likely operate healthcare service delivery, staffing, or telehealth operations. Daily operations typically involve patient/client management, clinical staff coordination, regulatory compliance, and revenue cycle management specific to healthcare verticals.
- CEO
- Greg Picou
- Headquarters
- TX
- Founded
- 2022
- FDD year
- 2025
- States available
- 5
FDD Item 7 · 2025 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Initial franchise fee | $55K | $55K |
| Working capital (3–6 mo) | $50K | $80K |
| Equipment, build-out, other | $63K | $228K |
| Total initial investment | $168K | $363K |
Source: NexGenEsis Healthcare 2025 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Single-unit · estimated
Returns at a glance
Indicative numbers using FDD Item 7 / Item 19 inputs and category-benchmarked cost ratios. Full single-unit, 25-unit portfolio, and LBO models (with every input editable to stress-test your own scenario) live on the financials page.
Store EBITDA · annual
$455K
18.0% margin
Unlevered ROIC
138%
EBITDA / total invested capital
Payback
9 mo
cash-on-cash, unlevered
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $168K – $363K
- Better than avg vs category
- Liquid capital req'd
- $50K – $80K
- Near category avg vs category
- Franchise fee
- $55K – $55K
- Near category avg vs category
- Royalty
- The greater of 7% of Gross Sales or $500 per month
- Ad fund
- 1.0%
- typical 3–5%
- Total fee load
- 8.0%
- vs 9–13% typical
- Payback period
- 0.5 yrs
- From FDD / Item 19
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Marketing / ad fund | 1.0% of gross sales |
| Technology fee | $300 |
| Transfer fee | $28K |
| Renewal fee | $6K |
| Total fee load | 8.0% of rev |
Financial Performance
- Avg gross sales
- $2.5M
- Per unit, per year
- Median gross sales
- N/A
- Avg ebitda
- $536K
- Reported as EBITDA in FDD Item 19
- Item 19 type
- ebitda
- Sample size
- 3 units
- vs category median 12 · small
- Range (low → high)
- $945K→$4.1M
- Cohort dispersion (min → max)
- Transparency
- 10 / 5
- vs category median 4 / 5 · above
Compared against 201 Healthcare brands
Revenue is 9.5x the investment midpoint. At typical franchise margins, this suggests a payback under 3 years.
vs Healthcare averages
How NexGenEsis Healthcare Compares
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 14
- Opened
- 5
- Last reporting year
- Closed
- 1
- Turnover rate
- 7.1%
- Company-owned
- 8
- Corporate units in the system
- % franchised
- 43%
- vs corporate-owned
- Net growth (yr3)
- +200.0%
- Net unit change last year
3-year detail · Item 20
- Transfers (3yr)
- 0
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 5 states reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
5
states with franchisees (per FDD Item 12)
Fast growth in a small system. Newer franchisors expanding quickly may not yet have the support infrastructure of larger systems.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
Risk analysis
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Rapidly scaling early-stage healthcare franchise with unverified unit economics, opaque financial disclosure, and high minimum royalties creates elevated risk despite strong headline metrics.
Audited financials (Item 21)
Yes · Kezos & Dunlavy⚠ Going-concern note flagged
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
Score breakdown · what drove the 44 / 100 rating
- 01MINORExplosive 200% YoY unit growth (14 units) suggests either aggressive recruitment or unsustainable expansion with unproven unit economics
- 02MINORHigh royalty floor ($500/month minimum) creates cash flow burden even for underperforming locations—problematic given only 14 units suggest immaturity
- 03MINORWide investment range ($168K–$363K) indicates inconsistent cost structure or territory-dependent pricing, reducing predictability
- 04MEDNo Item 19 (Franchisor Financial Performance) disclosed; cannot independently verify claimed $2M avg revenue and $536K net income
- 05MINORYoung franchise system (14 units) with minimal operating history; cannot validate sustainability of growth trajectory or franchisee profitability
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | Zip codes |
| Protected territory | Yes |
| Online sales rights | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Required |
| Non-compete (years)ℹ | 1 year |
| Right of first refusalℹ | Yes |
| Termination notice | 30 days |
| Mandatory arbitration | Yes |
| Jury trial waiver | Yes |
| Governing law | Texas |
| Litigation count | 0 |
Items 10, 11
Training & Operations
- Classroom training
- 20 hrs
- On-the-job training
- 22 hrs
- POS system
- QuickBooks and Microsoft 365
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: QuickBooks and Microsoft 365
Item 20 · call current owners
Franchisee Contacts
1 owners to call
Name · phone · city · state. Extracted from FDD Item 20
FDD download
NexGenEsis Healthcare · FDD (2025) PDF
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a NexGenEsis Healthcare franchise?
The total investment to open a NexGenEsis Healthcare franchise ranges from $168K – $363K, with an initial franchise fee of $55K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do NexGenEsis Healthcare franchise owners earn?
According to Item 19 of the NexGenEsis Healthcare FDD, the average gross sales per unit is $2.5M. Note: this is gross revenue, not profit. Actual owner earnings vary based on location, operating costs, and management.
What is NexGenEsis Healthcare's franchise failure rate?
SBA 7(a) loan charge-off data is not available for NexGenEsis Healthcare (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
How many NexGenEsis Healthcare franchise locations are there?
As of their most recent FDD filing, NexGenEsis Healthcare has 14 total units in the United States, including 0 franchised units and 8 company-owned units. 5 new units were opened in the latest reporting year.
Is NexGenEsis Healthcare a good franchise to buy?
FranchiseVerdict rates NexGenEsis Healthcare as a A-grade franchise with a risk score of 44 out of 100, based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent NexGenEsis Healthcare, you can request corrections or provide updated information.
Claim this brandOther Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.